NAVIDEA BIOPHARMACEUTICALS, INC.·4

Jun 30, 10:46 AM ET

Scott John K Jr. 4

4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jun 30, 2023

Insider Transaction Report

Form 4
Period: 2023-06-29
Transactions
  • Award

    Common Stock

    2023-06-29$0.09/sh+12,200,000$1,073,60031,755,832 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    10,139
  • Series G Redeemable Preferred Stock

    2,270
Footnotes (2)
  • [F1]Navidea entered into a Letter Agreement with the Reporting Person, pursuant to which the Company agreed to repay $1,073,600 principal amount of an outstanding Term Note by issuing to the Reporting Person 12,200,000 shares of Common Stock, based on the closing stock price of $0.088 per share on June 28, 2023.
  • [F2]Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed tohave shared voting and/or dispositive power with respect to such shares.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4